{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "discontinued_date": "01/20/2026",
      "update_type": "New",
      "initial_posting_date": "01/20/2026",
      "package_ndc": "49702-260-55",
      "generic_name": "Maraviroc Solution",
      "contact_info": "877-844-8872",
      "related_info": "The anticipated date that GSK will cease distribution of the product is approximately August 1, 2026.",
      "openfda": {
        "application_number": [
          "NDA208984"
        ],
        "brand_name": [
          "SELZENTRY"
        ],
        "generic_name": [
          "MARAVIROC"
        ],
        "manufacturer_name": [
          "ViiV Healthcare Company"
        ],
        "product_ndc": [
          "49702-260",
          "49702-223",
          "49702-224"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "rxcui": [
          "728223",
          "728225",
          "729201",
          "729203",
          "1857921",
          "1857925"
        ],
        "spl_id": [
          "bd98c45d-446e-4023-882c-9c36d612f5a5"
        ],
        "spl_set_id": [
          "46f30ac5-c96b-429e-976d-8c5ee1c0761b"
        ],
        "package_ndc": [
          "49702-223-18",
          "49702-224-18",
          "49702-260-55"
        ],
        "nui": [
          "N0000175572",
          "N0000175445"
        ],
        "pharm_class_epc": [
          "CCR5 Co-receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Chemokine Co-receptor 5 Antagonists [MoA]"
        ],
        "unii": [
          "MD6P741W8A"
        ]
      },
      "update_date": "01/20/2026",
      "therapeutic_category": [
        "Antiviral"
      ],
      "dosage_form": "Solution",
      "presentation": "Selzentry, Solution, 20 mg/mL Oral Solution Kit | 230 mL Oral Solution per Bottle | 1 Bottle per Carton  (NDC 49702-260-55)",
      "company_name": "ViiV Healthcare Company",
      "status": "To Be Discontinued"
    }
  ]
}